Clinical trials
Phase 4 Cardiomyopathies trials
Search ClinicalTrials.gov registrations by keyword, then narrow by condition, phase, status, country and start year.
28 trials match Source: ClinicalTrials.gov registrations
Trials started per year
By phase, 2000 to 2026.
| Category | Trials |
|---|---|
| 2001 | 2 |
| 2003 | 1 |
| 2004 | 2 |
| 2005 | 2 |
| 2006 | 3 |
| 2007 | 4 |
| 2008 | 1 |
| 2011 | 1 |
| 2013 | 1 |
| 2015 | 2 |
| 2017 | 1 |
| 2018 | 1 |
| 2021 | 1 |
| 2022 | 4 |
| 2025 | 1 |
| 2026 | 1 |
Status
Trials by registry status. Select a bar to filter.
| Category | Trials |
|---|---|
| Completed | 16 |
| Unknown status | 5 |
| Recruiting | 4 |
| Active, not recruiting | 1 |
| Suspended | 1 |
| Terminated | 1 |
Top lead sponsors
A sponsor with a page on Pharma Observatory links to it.
| Category | Trials |
|---|---|
| University of Rochester | 2 |
| Assistance Publique - Hôpitaux de Paris | 1 |
| Charite University, Berlin, Germany | 1 |
| Columbia University | 1 |
| Eidos Therapeutics, a BridgeBio company | 1 |
| Federal University of Minas Gerais | 1 |
| Hunter Holmes Mcguire Veteran Affairs Medical Center | 1 |
| LivaNova | 1 |
| Mayo Clinic | 1 |
| Medical University of Silesia | 1 |
Top conditions
MeSH conditions the trials were registered with, not their broader categories. A condition with a page on Pharma Observatory links to it.
| Category | Trials |
|---|---|
| Cardiomyopathies | 28 |
| Heart Failure | 7 |
| Arrhythmias, Cardiac | 2 |
| Cardiovascular Diseases | 2 |
| Coronary Artery Disease | 2 |
| Dyspnea | 2 |
| Myocarditis | 2 |
| Alcoholism | 1 |
| Alzheimer Disease | 1 |
| Amyloid Neuropathies, Familial | 1 |
Trials
Showing 26 to 28 of 28. Each trial links to its page on Pharma Observatory.
Recently changed trials
Changes observed in the last 7 days, newest first, site-count changes left out. Source: ClinicalTrials.gov.
No changes to these trials in the last 7 days.
Go deeper on Pharma Observatory
Pharma Observatory connects clinical trials, sponsors, sites and investigators in one searchable platform.